TYRP1 and amyloidosis: Using cultured cells and mouse AD models, pharmaceutical and genetic inhibition of CatB has been shown to reduce Aβ release and amyloid deposition and improve memory impairment.25,44 Recently, a strong correlation between severe periodontal disease and cognitive decline has been reported.